Publications - CuriRx

Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration

Introduction Antibodies 2020, 9(3), 36; https://doi.org/10.3390/antib9030036 (registering DOI) Received: 26 June 2020 / Revised: 21 July 2020 / Accepted: 23 July 2020 / Published: 29 July 2020 (This article […]

Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Improve HPLC Method

Introduction The latest publication from the CuriRx team illustrates an improved HPLC method to ensure better analyses and better separation of peaks regarding theoretical […]